All In MedTech

Device Trial Radar · NCT03456583

Brevera™ Breast Biopsy System Data Collection Study

A Prospective Study To Evaluate The Performance And Operation Of The Brevera™ Breast Biopsy System

Last checked: Nov 19, 2026Latest source record: Oct 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

500

Actual

Start

Nov 20, 2017

Primary completion

Nov 20, 2018

Study completion Nov 20, 2018

Sponsor

Lead sponsor
Hologic, Inc.Public (HOLX)
Sponsor type
Industry
First posted
Mar 7, 2018

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Brevera Breast Biopsy System integrates tissue acquisition, real time imaging, and post biopsy handling all during the same procedure. This post-market clinical trial will be performed to obtain clinical/operational data and feedback on the Brevera Breast Biopsy System.

Conditions

  • Breast Cancer Female

Interventions

  • Brevera Breast Biopsy SystemDevice

    The Brevera Breast Biopsy System with CorLumina imaging technology is a vacuum-assisted biopsy device, which is used to remove breast tissue in a minimally invasive manner using stereotactic or tomosynthesis imaging. A breast biopsy is a test that removes tissue or sometimes fluid from the suspicious area. The removed cells are examined under a microscope and further tested to check for the presence of breast cancer. A biopsy is a diagnostic procedure that can definitely determine if the suspicious area is cancerous.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Procedural TimeTime frame: Through study completion, enrollment expected to take up to 6-10 months at each site - Data collected from day of Breast Biopsy Procedure Only

Locations

6 sites in 6 countries. Site status is shown where the registry gives one.

  • Institut régional du Cancer de Montpellier

    Montpellier, France

  • Brustdiagnostik Munchen

    Tübingen, Germany

  • Radiologia Senologica

    Milan, Italy

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.